A pandemic’s impact on children’s mental health | Magellan Health Insights

A pandemic’s impact on children’s mental health | Magellan Health Insights

A pandemic’s impact on children’s mental health

by Magellan Health Insights

April 28, 2021 Children's mental health, Coronavirus, COVID-19, Magellan Health, Magellan Healthcare, Magellan Rx Management, Mental Health, Mental Health Condition, Mental Health Diagnosis, Mental Health Impact, pandemic

Navigating Autism | Magellan Health Insights

Navigating Autism

by Yagnesh Vadgama

April 26, 2021 Adolescent Behavioral Health, ASD, Autism, Autism Spec, Evidence-Based Practice, Magellan Health, Magellan Healthcare, Magellan Rx Management, Self-Care

The Future of Care for Oncology Patients | Magellan Health Insights

The Future of Care for Oncology Patients

by Magellan Health Insights

April 1, 2021 Cancer, Cancer treatment, Genomic Testing, Magellan Health, Magellan Healthcare, Oncology, Oncology Care, precision medicine, Precision Medicine in Oncology

A comprehensive approach to medical pharmacy savings: one plan’s real-word example

A comprehensive approach to medical pharmacy savings: one plan’s real-word example

by Magellan Health Insights

March 30, 2021 Magellan Health, Magellan Healthcare, Medical Pharmacy, Medical Pharmacy Management, Specialty Drug Management, specialty drugs

How are our kids doing?

by Magellan Health Insights

March 30, 2021 Adolescent Behavioral Health, Behavioral Health, Children's behavioral health, Coronavirus, coronavirus pandemic, COVID-19, Magellan Health, Magellan Healthcare, Mental Health, Mental Illness, Stress

Autism Spectrum Disorder - Celebrating 6 unique qualities | Magellan Health Insights

Autism Spectrum Disorder – Celebrating 6 unique qualities

by Yagnesh Vadgama

March 23, 2021 ABA, Applied Behavior Analysis, ASD, Autism, Autism Awareness, Autism Spectrum Disorder, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, National Autism Awareness Month

2020 FDA Approvals: A Year in Review

by Magellan Health Insights

March 15, 2021 CDER, Center for Drug Evaluation and Research, FDA, FDA Approvals, Food and Drug Administration, Magellan Health, New Drugs, Novel drugs, Orphan Drugs

Three Key Principles for Improving Patient Care with Behavioral Economics

by Magellan Health Insights

February 10, 2021 Behavioral Economics, Improving Patient Care, Magellan Health, Magellan Healthcare, Outcomes, Patient Care, Wellth